PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 112 filers reported holding PMV PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,813 | -1.9% | 11,533 | 0.0% | 0.02% | +14.3% |
| Q2 2023 | $72,197 | +31.2% | 11,533 | 0.0% | 0.02% | +10.5% |
| Q1 2023 | $55,012 | -45.2% | 11,533 | 0.0% | 0.02% | -44.1% |
| Q4 2022 | $100,337 | -26.8% | 11,533 | 0.0% | 0.03% | -24.4% |
| Q3 2022 | $137,000 | -16.5% | 11,533 | 0.0% | 0.04% | -16.7% |
| Q2 2022 | $164,000 | -31.7% | 11,533 | 0.0% | 0.05% | +10.2% |
| Q1 2022 | $240,000 | -9.8% | 11,533 | 0.0% | 0.05% | +44.1% |
| Q4 2021 | $266,000 | +16.2% | 11,533 | +49.9% | 0.03% | +54.5% |
| Q3 2021 | $229,000 | -12.9% | 7,692 | 0.0% | 0.02% | -12.0% |
| Q2 2021 | $263,000 | +4.0% | 7,692 | 0.0% | 0.02% | -26.5% |
| Q1 2021 | $253,000 | – | 7,692 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |